AI Science Tracker

Genetic reanalysis assisted by o3 contributes to 18 diagnoses

OpenAI; Boston Children’s Hospital, and Harvard University · 18 Jun 2026 · medicine

Discovery

Genetic reanalysis assisted by o3 contributes to 18 diagnoses

Among 376 unresolved cases, o3 Deep Research proposed explanations reviewed by specialists: 18 diagnoses were clinically confirmed, seven of which had already been established elsewhere but were missing from local records. This was a retrospective study across heterogeneous cohorts, without a measure of time saved or effect on care; clinicians made the decisions.

Technology: o3 Deep Research

Family o1 / o3: profile · models page

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Retrospective multicohort reanalysis of 376 unresolved cases; a diagnosis required a pathogenic or likely pathogenic variant confirmed in a CLIA-certified lab and returned to families, and seven rediscoveries were also reported.
  • Still unknown: The abstract states that the retrospective design motivates prospective multicenter evaluation with predefined endpoints, calibration reporting and comparator baselines.
  • AI role: An LLM ingested clinician notes, HPO terms and a filtered variant table and proposed candidate hypotheses for expert adjudication under ACMG/AMP criteria; experts made the classifications.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1056/AIcs2501343&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.